- Types of Eczema
- Child Eczema
- Causes & Triggers
- Living with Eczema
- Eczema Products
- Get Involved
March 10, 2015 – On March 9, 2015, NEA CEO Julie Block, 13-year old eczema patient Isaiah, 17-year old eczema patient Gracie, and their parents were present at an important Food and Drug Administrative (FDA) hearing regarding the unmet medical need for atopic dermatitis therapies in pediatrics.
March 5, 2015 – Check out this NPR piece on an important new study about how eczema affects the lives of people who have it by NEA Scientific Advisory Committee member Jonathan Silverberg, MD. Data from this study demonstrates the burden of living with eczema, which helps further the case for more eczema research.
February 24, 2015 – Introduction of peanut products into the diets of infants at high risk of developing peanut allergy was safe and led to an 81 percent reduction in the subsequent development of the allergy, a clinical trial has found.
February 10, 2015 – Efficacy of topical application of human breast milk on atopic eczema healing among infants.
January 6, 2015 – For the first time, a team led by researchers at the Icahn School of Medicine at Mount Sinai has proven that atopic dermatitis, also known as eczema, is an immune-driven (autoimmune) disease.
December 15, 2014 – Patients on subcutaneous dupilumab at 300 mg once weekly showed nearly an 80% reduction from baseline in Eczema Area and Severity Index scores after 16 weeks of treatment.
November 20, 2014 – Contact Dermatitis (CD) is a term used to describe the itchy skin reaction that can occur following topical contact (and sometimes oral, or airborne) with allergy-producing chemicals in the environment.
November 5, 2014 – Seborrheic dermatitis is a common skin condition that affects the areas of the body that have a high density of oil-producing (sebaceous) glands. It affects 1 to 5 percent of the general population, and often has a chronic, relapsing course.
May 27, 2014 – A team of Melbourne researchers have shown a recently discovered type of cell death called necroptosis could be the underlying cause of inflammatory disease.
May 26, 2014 – The prevalence of childhood eczema was 12.97% had mild disease, 26.0% had moderate disease, and 7.0% had severe disease.